These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 24621463)

  • 21. A dipeptidyl peptidase-4 inhibitor ameliorates hypertensive cardiac remodeling via angiotensin-II/sodium-proton pump exchanger-1 axis.
    Kawase H; Bando YK; Nishimura K; Aoyama M; Monji A; Murohara T
    J Mol Cell Cardiol; 2016 Sep; 98():37-47. PubMed ID: 27374118
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characteristics of vasorelaxation responses in a rat model of metabolic syndrome.
    Kagota S; Tanaka N; Kubota Y; Yamaguchi Y; Nakamura K; Kunitomo M; Shinozuka K
    Clin Exp Pharmacol Physiol; 2004 Dec; 31 Suppl 2():S54-6. PubMed ID: 15649291
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Corosolic acid prevents oxidative stress, inflammation and hypertension in SHR/NDmcr-cp rats, a model of metabolic syndrome.
    Yamaguchi Y; Yamada K; Yoshikawa N; Nakamura K; Haginaka J; Kunitomo M
    Life Sci; 2006 Nov; 79(26):2474-9. PubMed ID: 16959274
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serial changes in adipocytokines and cardiac function in a rat model of the metabolic syndrome.
    Yamaguchi T; Kitamori K; Ichihara G; Suzuki Y; Ochiai M; Yamada Y; Tada-Oikawa S; Tsuchikura S; Yamori Y; Ichihara S
    Clin Exp Pharmacol Physiol; 2013 Jul; 40(7):443-8. PubMed ID: 23659633
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pharmacological and clinical profile of a novel DPP-4 inhibitor teneligliptin hydrobromide hydrate (TENELIA(®)].
    Goda M; Akahoshi F; Ishii S; Terata R; Hayashi Y
    Nihon Yakurigaku Zasshi; 2013 Sep; 142(3):134-43. PubMed ID: 24025495
    [No Abstract]   [Full Text] [Related]  

  • 26. Phycocyanin prevents hypertension and low serum adiponectin level in a rat model of metabolic syndrome.
    Ichimura M; Kato S; Tsuneyama K; Matsutake S; Kamogawa M; Hirao E; Miyata A; Mori S; Yamaguchi N; Suruga K; Omagari K
    Nutr Res; 2013 May; 33(5):397-405. PubMed ID: 23684441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DPP-4 Inhibitor Teneligliptin Improves Insulin Resistance and Serum Lipid Profile in Japanese Patients with Type 2 Diabetes.
    Kusunoki M; Sato D; Nakamura T; Oshida Y; Tsutsui H; Natsume Y; Tsutsumi K; Miyata T
    Drug Res (Stuttg); 2015 Oct; 65(10):532-4. PubMed ID: 25368904
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lack of beneficial metabolic effects of quercetin in adult spontaneously hypertensive rats.
    Romero M; Jiménez R; Hurtado B; Moreno JM; Rodríguez-Gómez I; López-Sepúlveda R; Zarzuelo A; Pérez-Vizcaino F; Tamargo J; Vargas F; Duarte J
    Eur J Pharmacol; 2010 Feb; 627(1-3):242-50. PubMed ID: 19903466
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Teneligliptin Decreases Uric Acid Levels by Reducing Xanthine Dehydrogenase Expression in White Adipose Tissue of Male Wistar Rats.
    Moriya C; Satoh H
    J Diabetes Res; 2016; 2016():3201534. PubMed ID: 27652270
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peroxynitrite is Involved in the dysfunction of vasorelaxation in SHR/NDmcr-cp rats, spontaneously hypertensive obese rats.
    Kagota S; Tada Y; Kubota Y; Nejime N; Yamaguchi Y; Nakamura K; Kunitomo M; Shinozuka K
    J Cardiovasc Pharmacol; 2007 Dec; 50(6):677-85. PubMed ID: 18091585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Dipeptidyl Peptidase-4 Inhibitor Inhibits Foam Cell Formation of Macrophages in Type 1 Diabetes via Suppression of CD36 and ACAT-1 Expression.
    Terasaki M; Yashima H; Mori Y; Saito T; Matsui T; Hiromura M; Kushima H; Osaka N; Ohara M; Fukui T; Hirano T; Yamagishi SI
    Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32646003
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Dipeptidyl Peptidase-4 Inhibitor, Teneligliptin, Decreases Plasma Triglyceride-Rich Lipoprotein Remnants in Diabetic Patients with Chronic Kidney Disease Undergoing Hemodialysis.
    Homma K; Yoshizawa J; Shiina Y; Ozawa H; Igarashi M; Matsuoka T; Sasaki J; Yoshizawa M; Homma Y
    Drugs R D; 2017 Sep; 17(3):397-402. PubMed ID: 28577292
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of postprandial hyperglycemia by acarbose is a promising therapeutic strategy for the treatment of patients with the metabolic syndrome.
    Yamagishi S; Nakamura K; Takeuchi M
    Med Hypotheses; 2005; 65(1):152-4. PubMed ID: 15893133
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dipeptidyl peptidase-4 inhibition with saxagliptin enhanced nitric oxide release and reduced blood pressure and sICAM-1 levels in hypertensive rats.
    Mason RP; Jacob RF; Kubant R; Ciszewski A; Corbalan JJ; Malinski T
    J Cardiovasc Pharmacol; 2012 Nov; 60(5):467-73. PubMed ID: 22932707
    [TBL] [Abstract][Full Text] [Related]  

  • 35. (2S,4S)-4-Fluoro-1-{[(2-hydroxy-1,1-dimethylethyl)amino]acetyl}-pyrrolidine-2-carbonitrile monobenzenesulfonate (TS-021) is a selective and reversible dipeptidyl peptidase IV inhibitor.
    Tajima A; Yamamoto K; Kozakai A; Okumura-Kitajima L; Mita Y; Kitano K; Jingu S; Nakaike S
    Eur J Pharmacol; 2011 Mar; 655(1-3):99-107. PubMed ID: 21262219
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Teneligliptin improves left ventricular diastolic function and endothelial function in patients with diabetes.
    Hashikata T; Yamaoka-Tojo M; Kakizaki R; Nemoto T; Fujiyoshi K; Namba S; Kitasato L; Hashimoto T; Kameda R; Maekawa E; Shimohama T; Tojo T; Ako J
    Heart Vessels; 2016 Aug; 31(8):1303-10. PubMed ID: 26266630
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coronary vascular dysfunction promoted by oxidative-nitrative stress in SHRSP.Z-Lepr(fa) /IzmDmcr rats with metabolic syndrome.
    Kagota S; Fukushima K; Umetani K; Tada Y; Nejime N; Nakamura K; Mori H; Sugimura K; Kunitomo M; Shinozuka K
    Clin Exp Pharmacol Physiol; 2010 Nov; 37(11):1035-43. PubMed ID: 20659132
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of diuretics on sodium-dependent glucose cotransporter 2 inhibitor-induced changes in blood pressure in obese rats suffering from the metabolic syndrome.
    Rahman A; Kittikulsuth W; Fujisawa Y; Sufiun A; Rafiq K; Hitomi H; Nakano D; Sohara E; Uchida S; Nishiyama A
    J Hypertens; 2016 May; 34(5):893-906. PubMed ID: 26982381
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ameliorating effect of the novel dipeptidyl peptidase-4 inhibitor teneligliptin on psoriasis: A report of two cases.
    Nagai H; Fujiwara S; Takahashi Y; Nishigori C
    J Dermatol; 2015 Nov; 42(11):1094-7. PubMed ID: 26031638
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vildagliptin selectively ameliorates GLP-1, GLUT4, SREBP-1c mRNA levels and stimulates β-cell proliferation resulting in improved glucose homeostasis in rats with streptozotocin-induced diabetes.
    Akarte AS; Srinivasan BP; Gandhi S
    J Diabetes Complications; 2012; 26(4):266-74. PubMed ID: 22626875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.